Altimmune Inc (ALT)
7.26
+0.06
(+0.83%)
USD |
NASDAQ |
Apr 26, 16:00
7.26
0.00 (0.00%)
After-Hours: 20:00
Altimmune Cash from Investing (TTM): 13.73M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 13.73M |
September 30, 2023 | 22.67M |
June 30, 2023 | -7.133M |
March 31, 2023 | -60.09M |
December 31, 2022 | -73.40M |
September 30, 2022 | -49.51M |
June 30, 2022 | -5.697M |
March 31, 2022 | 68.35M |
December 31, 2021 | 87.52M |
September 30, 2021 | 25.65M |
June 30, 2021 | -40.64M |
March 31, 2021 | -59.62M |
December 31, 2020 | -72.23M |
September 30, 2020 | -35.28M |
June 30, 2020 | -15.61M |
March 31, 2020 | -21.72M |
December 31, 2019 | -28.29M |
September 30, 2019 | -28.24M |
June 30, 2019 | -0.1791M |
March 31, 2019 | -0.3379M |
December 31, 2018 | -1.001M |
September 30, 2018 | -1.022M |
June 30, 2018 | -0.8833M |
March 31, 2018 | 12.92M |
December 31, 2017 | 13.73M |
Date | Value |
---|---|
September 30, 2017 | 13.71M |
June 30, 2017 | 13.61M |
March 31, 2017 | -0.0773M |
December 31, 2016 | -0.2206M |
September 30, 2016 | -0.1976M |
June 30, 2016 | -0.0901M |
March 31, 2016 | -0.0513M |
December 31, 2015 | -0.0789M |
September 30, 2015 | -0.0607M |
June 30, 2015 | -0.0617M |
March 31, 2015 | -0.083M |
December 31, 2014 | -0.0843M |
September 30, 2014 | -0.0843M |
June 30, 2014 | -0.0817M |
March 31, 2014 | -0.0847M |
December 31, 2013 | -0.0811M |
September 30, 2013 | -0.0811M |
June 30, 2013 | -0.0706M |
March 31, 2013 | -0.0255M |
December 31, 2012 | 0.0674M |
September 30, 2012 | 1.826M |
June 30, 2012 | 1.785M |
March 31, 2012 | 1.755M |
December 31, 2011 | 1.688M |
September 30, 2011 | -0.1214M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-73.40M
Minimum
Dec 2022
87.52M
Maximum
Dec 2021
-14.72M
Average
-21.72M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.153B |
Amgen Inc | -26.20B |
Viking Therapeutics Inc | -641.08M |
Precision BioSciences Inc | 5.829M |
Terns Pharmaceuticals Inc | -37.99M |